CLINICA CHIMICA ACTA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-08-21 ms5000000982471463 来自浙江省

请问这个杂志可以共一和共通讯么

144 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2025-01-13 ms8000000046929109 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：免疫学检验;免疫组化
经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松.
审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了
大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了
感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄.
如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择
唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......

16 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-06-01 科研卡啦咪

偏重的研究方向：检验
经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。

116 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2020-04-15 夕*溦*

审稿速度:1.0 | 投稿命中率:75.0
经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。

222 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2021-04-03 zouseyin

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：标志物;临床检验
经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！

155 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-09-29 liufeng0113

偏重的研究方向：生物学标记物
经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？

141 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2024-02-08 ms1000000229351710 来自山东省

请教 Author Checklist怎么弄啊

104 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-12-29 1240adaem89暂无昵称来自四川省

这个杂志with editor一般持续多久呀？

136 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2023-08-04 ms5000000169069735 来自北京

author checklist 从哪里下载啊

133 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153841, encodeId=1ac9215384140, content=请问这个杂志可以共一和共通讯么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a38820327, createdName=ms5000000982471463, createdTime=Mon Aug 21 12:14:33 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2247881, encodeId=cf94224e8819b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫学检验;免疫组化 经验分享：9月初提交,十一前一天给了大修后审,过了一个很痛苦的十一,不过稿件给到的修改时间很宽松. 审稿人很专业,给的意见一针见血,很中肯,所以大修花了不少心思按审稿人意见一一修改了 大修提交是11-15,大修的审核很快,以至于编辑部给发的邮件漏看了还发了第二遍,好在及时发现,二修意见是小修后发表,赶在11月最后一天见刊了 感想是杂志还是蛮专业的,因为看文献的时候很多参考文献是来自他家,所以尝试投了一下,他家投稿的时候会让勾选,文章是否涉及方法学验证,人群参考范围,等等一些他们关注的方面,可能中稿不多的原因在这里?他们偏重的方向还是比较窄. 如果涉及方法学建立,方法学验证,还有一些其他该杂志常发的方向可以投投看,杂志给人的感觉是效率很高,不拖泥带水,宽容度也蛮高,以后有机会还会优先选择 唯一比较不习惯的是他们的审稿系统,提交按钮特别的没有仪式感,以至于我误提交了两次未修改的稿件......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ad36461429, createdName=ms8000000046929109, createdTime=Mon Jan 13 14:27:05 CST 2025, time=2025-01-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1223827, encodeId=b76d122382e47, content=偏重的研究方向：检验 经验分享：大修后 Under Review突然慢下来了。4月21投稿，5月16就返修，感觉速度非常快，系好安全带。一周后提交修改稿以后，到现在一周多了，一直是Under Review，爱思唯尔出了个新功能，能看到，编辑发了几个审稿邀请，有几个接收了，有几个完成的。24号看这个流程，一个专家很快complete，另外一个专家24号也接收了邀请，但是一直没有完成，突然很怕中间出幺蛾子啊。要是拒的话痛快点也行，这么憋着太难受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25bc8180016, createdName=科研卡啦咪, createdTime=Wed Jun 01 11:23:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588904, encodeId=9806588904f5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：接收了一篇遗传学方向的文章，审稿周期：3个月左右，分享一下这个杂志的审稿时间段，我觉得算快的了。 1.6 submit；1.13 under review; 2.5 major revision; 3.7修回 with editor; 3.10再次 under review; 4.7 accept; 4.9 proof. 每次投稿选杂志都喜欢来williamhill asia 看一下评论，很有帮助，现在也会分享一些自己的投稿经历，希望能帮助你们。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2DLia1AHLyViabxtHicQW1UGMicF5c0Aq43AdRnbO16cMCPPGUKEL3S4McZ5txaicI9eWfgW4OES53dfbzv3ib0KpFgw/132, createdBy=05e72531160, createdName=夕*溦*, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953484, encodeId=333d9534848b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：标志物;临床检验 经验分享：投稿前在williamhill asia 上收获了很多的信息和帮助，现在文章接收了，也来分享一下我的投稿经历和感受：编辑很nice，速度也非常快，1.14投稿，2.9返修大修，2.23修回，3.25文章接收，整个过程2个月多一点，算是非常高效的了，作为作者能碰到这样高效的杂志真的是非常的幸运，也非常感谢williamhill asia 能提供这样的平台和信息供大家借鉴和参考，希望williamhill asia 一如既往的好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=409c104437, createdName=zouseyin, createdTime=Sat Apr 03 11:27:07 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090943, encodeId=71002090943b3, content=偏重的研究方向：生物学标记物 经验分享：生物学标记物这方面的，投稿1周，没有审稿，直接decision in process了，是不是要被拒稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7daa1592248, createdName=liufeng0113, createdTime=Thu Sep 29 08:57:12 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186585, encodeId=06e92186585ac, content=请教 Author Checklist怎么弄啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c5e8249461, createdName=ms1000000229351710, createdTime=Thu Feb 08 20:14:44 CST 2024, time=2024-02-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177982, encodeId=1bed21e798200, content=这个杂志with editor一般持续多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Fri Dec 29 12:59:46 CST 2023, time=2023-12-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151315, encodeId=762121513156f, content=author checklist 从哪里下载啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Fri Aug 04 19:11:13 CST 2023, time=2023-08-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183877, encodeId=405e11838e772, content=请问authr checklist怎么弄啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Thu Jan 13 13:52:30 CST 2022, time=2022-01-13, status=1, ipAttribution=)]

2022-01-13 阿杰11

请问authr checklist怎么弄啊

143 3 举报

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务